APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 143 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $376,294,415 | -32.7% | 9,809,552 | +3.2% | 0.01% | -36.4% |
Q1 2024 | $558,754,804 | -2.3% | 9,505,866 | -0.5% | 0.01% | -8.3% |
Q4 2023 | $572,002,885 | +58.8% | 9,555,678 | +0.9% | 0.01% | +33.3% |
Q3 2023 | $360,237,925 | -57.9% | 9,469,977 | +0.7% | 0.01% | -55.0% |
Q2 2023 | $856,457,519 | +36.3% | 9,401,290 | -1.3% | 0.02% | +25.0% |
Q1 2023 | $628,529,146 | +31.9% | 9,528,944 | +3.4% | 0.02% | +23.1% |
Q4 2022 | $476,377,910 | -22.8% | 9,212,491 | +2.0% | 0.01% | -27.8% |
Q3 2022 | $616,823,000 | +56.3% | 9,031,079 | +3.5% | 0.02% | +63.6% |
Q2 2022 | $394,623,000 | -9.4% | 8,726,745 | +1.8% | 0.01% | +10.0% |
Q1 2022 | $435,400,000 | +16.3% | 8,569,170 | +8.2% | 0.01% | +25.0% |
Q4 2021 | $374,320,000 | +68.2% | 7,917,099 | +17.3% | 0.01% | +33.3% |
Q3 2021 | $222,555,000 | -44.5% | 6,752,285 | +6.4% | 0.01% | -40.0% |
Q2 2021 | $400,969,000 | +53.1% | 6,344,456 | +3.9% | 0.01% | +42.9% |
Q1 2021 | $261,945,000 | -17.4% | 6,104,517 | +10.2% | 0.01% | -22.2% |
Q4 2020 | $316,992,000 | +143.3% | 5,541,825 | +28.3% | 0.01% | +125.0% |
Q3 2020 | $130,285,000 | -9.1% | 4,318,357 | -1.6% | 0.00% | -20.0% |
Q2 2020 | $143,318,000 | +76.4% | 4,388,181 | +44.7% | 0.01% | +66.7% |
Q1 2020 | $81,267,000 | +9.9% | 3,033,471 | +25.6% | 0.00% | 0.0% |
Q4 2019 | $73,926,000 | +42.3% | 2,414,314 | +11.9% | 0.00% | +50.0% |
Q3 2019 | $51,965,000 | -0.0% | 2,157,086 | +5.2% | 0.00% | 0.0% |
Q2 2019 | $51,968,000 | +33.0% | 2,050,838 | +2.4% | 0.00% | 0.0% |
Q1 2019 | $39,064,000 | +105.7% | 2,003,283 | +39.1% | 0.00% | +100.0% |
Q4 2018 | $18,994,000 | -24.5% | 1,440,038 | +1.8% | 0.00% | 0.0% |
Q3 2018 | $25,157,000 | -14.8% | 1,414,900 | +5.4% | 0.00% | 0.0% |
Q2 2018 | $29,530,000 | +249.0% | 1,342,290 | +250.8% | 0.00% | – |
Q1 2018 | $8,461,000 | +42.3% | 382,653 | +39.6% | 0.00% | – |
Q4 2017 | $5,947,000 | – | 274,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |